Insider Trading disclosures for Catalyst Biosciences Inc

The latest disclosure was made by Nassim Usman in Catalyst Biosciences Inc where a trade of 3,250 Common Stock done at an average price of $0.5 was reported to US exchanges on Aug. 9, 2022.

Insider trading is the trading of a company’s securities by individuals with access to confidential or material non-public information about the company. A company is required to report trading by corporate officers, directors, or other company members with significant access to privileged information to the Securities and Exchange Commission (SEC).

Client Name	Client Category	Action	Reported to Exchange	Quantity	Post Transaction Holding	Traded %	Avg. Price	Value	Security Type
Nassim Usman	Director, President & CEO	Purchase of securities on an exchange or from another person at price $ 0.47 per share.	09 Aug 2022	3,250	24,541 (0%)	0%	0.5	1,528	Common Stock
Grant E. Blouse	Chief Scientific Officer	Purchase of securities on an exchange or from another person at price $ 0.47 per share.	09 Aug 2022	3,250	9,417 (0%)	0%	0.5	1,528	Common Stock
Seline Miller	SVP Finance; Interim CFO & PAO	Purchase of securities on an exchange or from another person at price $ 0.47 per share.	09 Aug 2022	3,250	6,500 (0%)	0%	0.5	1,528	Common Stock
Grant E. Blouse	Chief Scientific Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	11 Feb 2022	200,000	200,000	-		-	Stock Option (Right to Buy)
Seline Miller	SVP Finance; Interim CFO & PAO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	11 Feb 2022	107,500	107,500	-		-	Stock Option (Right to Buy)
Nassim Usman	Director, President & CEO	Purchase of securities on an exchange or from another person at price $ 0.46 per share.	09 Feb 2022	3,250	21,291 (0%)	0%	0.5	1,495	Common Stock
Grant E. Blouse	Chief Scientific Officer	Purchase of securities on an exchange or from another person at price $ 0.46 per share.	09 Feb 2022	3,250	6,167 (0%)	0%	0.5	1,495	Common Stock
Seline Miller	SVP Finance; Interim CFO & PAO	Purchase of securities on an exchange or from another person at price $ 0.46 per share.	09 Feb 2022	3,250	3,250 (0%)	0%	0.5	1,495	Common Stock
Andrea S. Hunt	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	07 Jan 2022	7,521	28,228 (0%)	0%		0	Common Stock
Edward Williams	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	07 Jan 2022	12,308	34,804 (0%)	0%		0	Common Stock
Geoffrey Shiu Fei Ling	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	07 Jan 2022	12,855	31,790 (0%)	0%		0	Common Stock
Augustine J. Lawlor	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Oct 2021	5,839	24,573 (0%)	0%		0	Common Stock
Desouza B Errol	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Oct 2021	3,588	29,801 (0%)	0%		0	Common Stock
Andrea S. Hunt	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Oct 2021	1,824	20,707 (0%)	0%		0	Common Stock
Edward Williams	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Oct 2021	2,980	22,496 (0%)	0%		0	Common Stock
Geoffrey Shiu Fei Ling	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Oct 2021	2,858	18,935 (0%)	0%		0	Common Stock
Jeanne Y. Jew	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	09 Sep 2021	28,000	28,000	-		-	Stock Option (Right to Buy)
Nassim Usman	Director, President & CEO	Purchase of securities on an exchange or from another person at price $ 3.62 per share.	09 Aug 2021	867	18,041 (0%)	0%	3.6	3,139	Common Stock
Howard Levy	Chief Medical Officer	Purchase of securities on an exchange or from another person at price $ 3.62 per share.	09 Aug 2021	639	639 (0%)	0%	3.6	2,313	Common Stock
Grant E. Blouse	Chief Scientific Officer	Purchase of securities on an exchange or from another person at price $ 3.62 per share.	09 Aug 2021	1,163	2,917 (0%)	0%	3.6	4,210	Common Stock
Augustine J. Lawlor	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	09 Jun 2021	5,542	18,734 (0%)	0%		0	Common Stock
Augustine J. Lawlor	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	09 Jun 2021	14,000	14,000	-		-	Stock Option (Right to Buy)
Desouza B Errol	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	09 Jun 2021	14,000	14,000	-		-	Stock Option (Right to Buy)
Desouza B Errol	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	09 Jun 2021	3,406	26,213 (0%)	0%		0	Common Stock
Sharon E. Tetlow	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	09 Jun 2021	14,000	14,000	-		-	Stock Option (Right to Buy)
Andrea S. Hunt	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	09 Jun 2021	2,886	18,883 (0%)	0%		0	Common Stock
Andrea S. Hunt	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	09 Jun 2021	14,000	14,000	-		-	Stock Option (Right to Buy)
Edward Williams	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	09 Jun 2021	14,000	14,000	-		-	Stock Option (Right to Buy)
Edward Williams	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	09 Jun 2021	1,414	19,516 (0%)	0%		0	Common Stock
Geoffrey Shiu Fei Ling	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	09 Jun 2021	2,713	16,077 (0%)	0%		0	Common Stock
Geoffrey Shiu Fei Ling	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	09 Jun 2021	14,000	14,000	-		-	Stock Option (Right to Buy)
Nassim Usman	Director, President & CEO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.63 per share.	05 Apr 2021	5,000	17,174 (0%)	0%	4.6	23,150	Common Stock
Nassim Usman	Director, President & CEO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	05 Apr 2021	5,000	259,783	-		-	Stock Option (Right to Buy)
Augustine J. Lawlor	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Apr 2021	4,761	13,192 (0%)	0%		0	Common Stock
Desouza B Errol	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Apr 2021	2,926	22,807 (0%)	0%		0	Common Stock
Andrea S. Hunt	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Apr 2021	2,480	15,997 (0%)	0%		0	Common Stock
Edward Williams	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Apr 2021	1,215	18,102 (0%)	0%		0	Common Stock
Geoffrey Shiu Fei Ling	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Apr 2021	2,331	13,364 (0%)	0%		0	Common Stock
Nassim Usman	Director, President & CEO	Purchase of securities on an exchange or from another person at price $ 4.81 per share.	09 Feb 2021	582	12,174 (0%)	0%	4.8	2,799	Common Stock
Howard Levy	Chief Medical Officer	Purchase of securities on an exchange or from another person at price $ 4.81 per share.	09 Feb 2021	1,670	23,390 (0%)	0%	4.8	8,033	Common Stock
Nassim Usman	Director, President & CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	08 Feb 2021	140,000	140,000	-		-	Stock Option (Right to Buy)
Howard Levy	Chief Medical Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	08 Feb 2021	25,000	25,000	-		-	Stock Option (Right to Buy)
Clinton Musil	Chief Financial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	08 Feb 2021	54,000	54,000	-		-	Stock Option (Right to Buy)
Augustine J. Lawlor	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	05 Jan 2021	3,417	8,431 (0%)	0%		0	Common Stock
Desouza B Errol	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	05 Jan 2021	2,129	19,881 (0%)	0%		0	Common Stock
Andrea S. Hunt	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	05 Jan 2021	1,881	13,517 (0%)	0%		0	Common Stock
Edward Williams	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	05 Jan 2021	940	16,887 (0%)	0%		0	Common Stock
Geoffrey Shiu Fei Ling	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	05 Jan 2021	1,782	11,033 (0%)	0%		0	Common Stock
Augustine J. Lawlor	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Oct 2020	5,014	5,014 (0%)	0%		0	Common Stock
Desouza B Errol	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Oct 2020	3,125	17,752 (0%)	0%		0	Common Stock
Andrea S. Hunt	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Oct 2020	2,761	11,636 (0%)	0%		0	Common Stock
Edward Williams	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Oct 2020	1,380	15,947 (0%)	0%		0	Common Stock
Geoffrey Shiu Fei Ling	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Oct 2020	2,616	9,251 (0%)	0%		0	Common Stock
Nassim Usman	Director, President & CEO	Purchase of securities on an exchange or from another person at price $ 4.81 per share.	10 Aug 2020	582	11,592 (0%)	0%	4.8	2,799	Common Stock
Howard Levy	Chief Medical Officer	Purchase of securities on an exchange or from another person at price $ 4.81 per share.	10 Aug 2020	1,768	4,268 (0%)	0%	4.8	8,504	Common Stock
Augustine J. Lawlor	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Jul 2020	3,673	24,215 (0%)	0%		0	Common Stock
Desouza B Errol	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Jul 2020	2,129	14,627 (0%)	0%		0	Common Stock
Sharon E. Tetlow	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Jul 2020	1,703	3,635 (0%)	0%		0	Common Stock
Andrea S. Hunt	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Jul 2020	2,076	8,875 (0%)	0%		0	Common Stock
Edward Williams	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Jul 2020	1,011	14,567 (0%)	0%		0	Common Stock
Clinton Musil	Chief Financial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Jul 2020	140,000	140,000	-		-	Stock Option (Right to Buy)
Geoffrey Shiu Fei Ling	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Jul 2020	1,703	6,635 (0%)	0%		0	Common Stock
Augustine J. Lawlor	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	11 Jun 2020	5,000	5,000	-		-	Stock Option (Right to Buy)
Desouza B Errol	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	11 Jun 2020	5,000	5,000	-		-	Stock Option (Right to Buy)
Sharon E. Tetlow	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	11 Jun 2020	5,000	5,000	-		-	Stock Option (Right to Buy)
Andrea S. Hunt	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	11 Jun 2020	5,000	5,000	-		-	Stock Option (Right to Buy)
Edward Williams	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	11 Jun 2020	5,000	5,000	-		-	Stock Option (Right to Buy)
Geoffrey Shiu Fei Ling	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	11 Jun 2020	5,000	5,000	-		-	Stock Option (Right to Buy)
Augustine J. Lawlor	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Apr 2020	4,934	20,542 (0%)	0%		0	Common Stock
Desouza B Errol	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Apr 2020	2,860	12,498 (0%)	0%		0	Common Stock
Sharon E. Tetlow	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Apr 2020	1,932	1,932 (0%)	0%		0	Common Stock
Andrea S. Hunt	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Apr 2020	1,673	6,799 (0%)	0%		0	Common Stock
Edward Williams	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Apr 2020	2,717	13,556 (0%)	0%		0	Common Stock
Geoffrey Shiu Fei Ling	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Apr 2020	1,932	4,932 (0%)	0%		0	Common Stock
Howard Levy	Chief Medical Officer	Purchase of securities on an exchange or from another person at price $ 4.05 per share.	16 Mar 2020	2,500	2,500 (0%)	0%	4.1	10,132	Common Stock
John P. Richard	Director	Purchase of securities on an exchange or from another person at price $ 3.98 per share.	13 Mar 2020	2,500	3,716 (0%)	0%	4.0	9,950	Common Stock
Nassim Usman	Director, President & CEO	Purchase of securities on an exchange or from another person at price $ 3.91 per share.	13 Mar 2020	4,000	11,010 (0%)	0%	3.9	15,647	Common Stock
Veronica Cai	Controller	Purchase of securities on an exchange or from another person at price $ 4.11 per share.	13 Mar 2020	2,000	7,353 (0%)	0%	4.1	8,220	Common Stock
Edward Williams	Director	Purchase of securities on an exchange or from another person at price $ 5.78 per share.	04 Mar 2020	2,000	10,839 (0%)	0%	5.8	11,560	Common Stock
Augustine J. Lawlor	Director	Sale of securities on an exchange or to another person at price $ 6.10 per share.	25 Feb 2020	69,401	0 (0%)	0%	6.1	423,506	Common Stock
Geoffrey Shiu Fei Ling	Director	Purchase of securities on an exchange or from another person at price $ 6.23 per share.	25 Feb 2020	3,000	3,000 (0%)	0%	6.2	18,692	Common Stock
Nassim Usman	Director, President & CEO	Grant, award, or other acquisition of securities at price $ 6.23 per share.	10 Feb 2020	430	7,010 (0%)	0%	6.2	2,679	Common Stock
Howard Levy	Chief Medical Officer	Grant, award, or other acquisition of securities at price $ 6.23 per share.	10 Feb 2020	1,358	1,358 (0%)	0%	6.2	8,460	Common Stock
Veronica Cai	Controller	Grant, award, or other acquisition of securities at price $ 6.23 per share.	10 Feb 2020	1,678	5,353 (0%)	0%	6.2	10,454	Common Stock
Nassim Usman	Director, President & CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jan 2020	115,000	115,000	-		-	Stock Option (Right to Buy)
Howard Levy	Chief Medical Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jan 2020	45,000	45,000	-		-	Stock Option (Right to Buy)
Veronica Cai	Controller	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jan 2020	12,000	12,000	-		-	Stock Option (Right to Buy)
Sharon E. Tetlow	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	15 Jan 2020	10,000	10,000	-		-	Stock Option (Right to Buy)
Geoffrey Shiu Fei Ling	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	15 Jan 2020	10,000	10,000	-		-	Stock Option (Right to Buy)
Augustine J. Lawlor	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	02 Jan 2020	3,166	15,608 (0%)	0%		0	Common Stock
Desouza B Errol	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	02 Jan 2020	1,835	9,638 (0%)	0%		0	Common Stock
Andrea S. Hunt	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	02 Jan 2020	1,073	5,126 (0%)	0%		0	Common Stock
Edward Williams	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	02 Jan 2020	1,743	8,839 (0%)	0%		0	Common Stock
Augustine J. Lawlor	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Oct 2019	4,391	12,442 (0%)	0%		0	Common Stock
Desouza B Errol	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Oct 2019	2,545	7,803 (0%)	0%		0	Common Stock
Andrea S. Hunt	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Oct 2019	1,489	4,053 (0%)	0%		0	Common Stock
Edward Williams	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Oct 2019	2,418	7,096 (0%)	0%		0	Common Stock
Veronica Cai	Controller	Grant, award, or other acquisition of securities at price $ 0.00 per share.	16 Sep 2019	3,000	3,000	-		-	Stock Option (Right to Buy)
Nassim Usman	Director, President & CEO	Grant, award, or other acquisition of securities at price $ 6.51 per share.	12 Aug 2019	413	6,580 (0%)	0%	6.5	2,689	Common Stock
Fletcher Payne	Chief Financial Officer	Grant, award, or other acquisition of securities at price $ 6.51 per share.	12 Aug 2019	1,180	3,744 (0%)	0%	6.5	7,682	Common Stock
Augustine J. Lawlor	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Jul 2019	2,905	8,051 (0%)	0%		0	Common Stock
Desouza B Errol	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Jul 2019	1,810	5,258 (0%)	0%		0	Common Stock
Andrea S. Hunt	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Jul 2019	1,036	2,564 (0%)	0%		0	Common Stock
Edward Williams	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Jul 2019	1,642	4,678 (0%)	0%		0	Common Stock
Augustine J. Lawlor	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	13 Jun 2019	5,000	5,000	-		-	Stock Option (Right to Buy)
Desouza B Errol	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	13 Jun 2019	5,000	5,000	-		-	Stock Option (Right to Buy)
John P. Richard	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	13 Jun 2019	5,000	5,000	-		-	Stock Option (Right to Buy)
Andrea S. Hunt	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	13 Jun 2019	5,000	5,000	-		-	Stock Option (Right to Buy)
Edward Williams	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	13 Jun 2019	5,000	5,000	-		-	Stock Option (Right to Buy)
John P. Richard	Director	Purchase of securities on an exchange or from another person at price $ 8.03 per share.	24 May 2019	1,000	1,216 (0%)	0%	8.0	8,030	Common Stock
Nassim Usman	Director, President & CEO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.63 per share.	21 May 2019	4,400	10,567 (0%)	0%	4.6	20,372	Common Stock
Nassim Usman	Director, President & CEO	Gift of securities by or to the insider at price $ 0.00 per share.	21 May 2019	4,400	6,167 (0%)	0%		0	Common Stock
Nassim Usman	Director, President & CEO	Gift of securities by or to the insider at price $ 0.00 per share.	21 May 2019	4,400	8,456 (0%)	0%		0	Common Stock
Nassim Usman	Director, President & CEO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	21 May 2019	4,400	264,783	-		-	Stock Option (Right to Buy)
Howard Levy	Chief Medical Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	21 May 2019	4,400	81,218	-		-	Stock Option (Right to Buy)
Howard Levy	Chief Medical Officer	Gift of securities by or to the insider at price $ 0.00 per share.	21 May 2019	16,094	16,094 (0%)	0%		0	Common Stock
Howard Levy	Chief Medical Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.63 per share.	21 May 2019	4,400	16,094 (0%)	0%	4.6	20,372	Common Stock
Augustine J. Lawlor	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Apr 2019	2,414	5,146 (0%)	0%		0	Common Stock
Desouza B Errol	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Apr 2019	1,504	3,448 (0%)	0%		0	Common Stock
Andrea S. Hunt	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Apr 2019	717	1,528 (0%)	0%		0	Common Stock
Edward Williams	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Apr 2019	1,364	3,036 (0%)	0%		0	Common Stock
Nassim Usman	Director, President & CEO	Grant, award, or other acquisition of securities at price $ 7.04 per share.	11 Feb 2019	350	6,167 (0%)	0%	7.0	2,464	Common Stock
Fletcher Payne	Chief Financial Officer	Grant, award, or other acquisition of securities at price $ 7.04 per share.	11 Feb 2019	1,002	3,731 (0%)	0%	7.0	7,054	Common Stock
Fletcher Payne	Chief Financial Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.63 per share.	04 Feb 2019	1,503	3,230 (0%)	0%	4.6	6,959	Common Stock
Fletcher Payne	Chief Financial Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	04 Feb 2019	1,503	73,497	-		-	Stock Option (Right to Buy)
Nassim Usman	Director, President & CEO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.63 per share.	31 Jan 2019	5,729	11,041 (0%)	0%	4.6	26,525	Common Stock
Nassim Usman	Director, President & CEO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	31 Jan 2019	5,729	269,271	-		-	Stock Option (Right to Buy)
Howard Levy	Chief Medical Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	31 Jan 2019	1,500	93,500	-		-	Stock Option (Right to Buy)
Howard Levy	Chief Medical Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.63 per share.	31 Jan 2019	1,500	9,382 (0%)	0%	4.6	6,945	Common Stock
Nassim Usman	Director, President and CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	24 Jan 2019	80,000	80,000	-		-	Stock Option (Right to Buy)
Fletcher Payne	Chief Financial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	24 Jan 2019	38,000	38,000	-		-	Stock Option (Right to Buy)
Howard Levy	Chief Medical Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	24 Jan 2019	35,000	35,000	-		-	Stock Option (Right to Buy)
Augustine J. Lawlor	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	31 Dec 2018	2,732	2,732 (0%)	0%		0	Common Stock
Desouza B Errol	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	31 Dec 2018	1,703	1,944 (0%)	0%		0	Common Stock
Andrea S. Hunt	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	31 Dec 2018	811	811 (0%)	0%		0	Common Stock
Edward Williams	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	31 Dec 2018	1,544	1,672 (0%)	0%		0	Common Stock
Howard Levy	Chief Medical Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.63 per share.	26 Nov 2018	149	7,709 (0%)	0%	4.6	690	Common Stock
Howard Levy	Chief Medical Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	26 Nov 2018	149	87,118	-		-	Stock Option (Right to Buy)
Howard Levy	Chief Medical Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	16 Nov 2018	173	87,267	-		-	Stock Option (Right to Buy)
Howard Levy	Chief Medical Officer	Sale of securities on an exchange or to another person at price $ 11.00 per share.	16 Nov 2018	173	7,560 (0%)	0%	11	1,903	Common Stock
Howard Levy	Chief Medical Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.63 per share.	16 Nov 2018	173	7,733 (0%)	0%	4.6	801	Common Stock
Stephen A. Hill	None	Sale or transfer of securities back to the company at price $ 10.07 per share.	06 Sep 2018	190	1,190 (0%)	0%	10.1	1,913	Common Stock
Nassim Usman	Director, President & CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	30 Jul 2018	75,000	75,000	-		-	Stock Option (Right to Buy)
Fletcher Payne	Chief Financial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	30 Jul 2018	25,000	25,000	-		-	Stock Option (Right to Buy)
Howard Levy	Chief Medical Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	30 Jul 2018	35,000	35,000	-		-	Stock Option (Right to Buy)
Augustine J. Lawlor	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	13 Jun 2018	5,000	5,000	-		-	Stock Option (Right to Buy)
Desouza B Errol	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	13 Jun 2018	5,000	5,000	-		-	Stock Option (Right to Buy)
John P. Richard	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	13 Jun 2018	5,000	5,000	-		-	Stock Option (Right to Buy)
Stephen A. Hill	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	13 Jun 2018	5,000	5,000	-		-	Stock Option (Right to Buy)
Andrea S. Hunt	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	13 Jun 2018	5,000	5,000	-		-	Stock Option (Right to Buy)
Edward Williams	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	13 Jun 2018	5,000	5,000	-		-	Stock Option (Right to Buy)
Howard Levy	Chief Medical Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.63 per share.	03 May 2018	7,560	7,560 (0%)	0%	4.6	35,003	Common Stock
Howard Levy	Chief Medical Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	03 May 2018	7,560	87,440	-		-	Stock Option (Right to Buy)
Nassim Usman	Director, President & CEO	Gift of securities by or to the insider at price $ 0.00 per share.	09 Apr 2018	88	0 (0%)	0%		0	Common Stock
Nassim Usman	Director, President & CEO	Gift of securities by or to the insider at price $ 0.00 per share.	09 Apr 2018	88	4,144 (0%)	0%		0	Common Stock
Nassim Usman	Director, President & CEO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	04 Apr 2018	88	274,912	-		-	Stock Option (Right to Buy)
Nassim Usman	Director, President & CEO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.62 per share.	04 Apr 2018	88	88 (0%)	0%	4.6	407	Common Stock
Fletcher Payne	Chief Financial Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	26 Mar 2018	59	74,941	-		-	Stock Option (Right to Buy)
Fletcher Payne	Chief Financial Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.63 per share.	26 Mar 2018	59	59 (0%)	0%	4.6	273	Common Stock
Flynn E James	Other	Sale of securities on an exchange or to another person at price $ 29.94 per share.	06 Mar 2018	3,617	322,076 (2%)	0%	29.9	108,293	Common Stock
Flynn E James	Other	Sale of securities on an exchange or to another person at price $ 29.03 per share.	06 Mar 2018	2,233	305,965 (2%)	0%	29.0	64,824	Common Stock
Flynn E James	Other	Sale of securities on an exchange or to another person at price $ 29.03 per share.	06 Mar 2018	5,890	807,257 (7%)	0%	29.0	170,987	Common Stock
Flynn E James	Other	Sale of securities on an exchange or to another person at price $ 30.00 per share.	06 Mar 2018	328	308,198 (2%)	0%	30	9,840	Common Stock
Flynn E James	Other	Sale of securities on an exchange or to another person at price $ 30.00 per share.	06 Mar 2018	866	813,147 (7%)	0%	30	25,980	Common Stock
Flynn E James	Other	Sale of securities on an exchange or to another person at price $ 30.00 per share.	06 Mar 2018	2,748	308,526 (2%)	0%	30	82,440	Common Stock
Flynn E James	Other	Sale of securities on an exchange or to another person at price $ 30.00 per share.	06 Mar 2018	7,252	814,013 (7%)	0%	30	217,560	Common Stock
Flynn E James	Other	Sale of securities on an exchange or to another person at price $ 31.18 per share.	06 Mar 2018	10,802	311,274 (2%)	0%	31.2	336,806	Common Stock
Flynn E James	Other	Sale of securities on an exchange or to another person at price $ 31.18 per share.	06 Mar 2018	28,498	821,265 (7%)	0%	31.2	888,568	Common Stock
Flynn E James	Other	Sale of securities on an exchange or to another person at price $ 29.94 per share.	06 Mar 2018	9,544	849,763 (7%)	0%	29.9	285,747	Common Stock
Desouza B Errol	None	Other type of transaction at price $ 0.00 per share.	20 Feb 2018	4,679	0	-		-	Redeemable Convertible Note
Stephen A. Hill	None	Other type of transaction at price $ 0.00 per share.	20 Feb 2018	21,600	0	-		-	Redeemable Convertible Note
Harold E. Selick	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	16 Jan 2018	10,000	10,000	-		-	Stock Option (Right to Buy)
Harold E. Selick	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	16 Jan 2018	500	500	-		-	Stock Option (Right to Buy)
Harold E. Selick	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	16 Jan 2018	550	550	-		-	Stock Option (Right to Buy)
Harold E. Selick	None	Sale or transfer of securities back to the company at price $ 0.00 per share.	16 Jan 2018	550	0	-		-	Stock Option (Right to Buy)
Harold E. Selick	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	16 Jan 2018	197	197	-		-	Stock Option (Right to Buy)
Harold E. Selick	None	Sale or transfer of securities back to the company at price $ 0.00 per share.	16 Jan 2018	197	0	-		-	Stock Option (Right to Buy)
Harold E. Selick	None	Sale or transfer of securities back to the company at price $ 0.00 per share.	16 Jan 2018	10,000	0	-		-	Stock Option (Right to Buy)
Harold E. Selick	None	Sale or transfer of securities back to the company at price $ 0.00 per share.	16 Jan 2018	500	0	-		-	Stock Option (Right to Buy)
Harold E. Selick	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	16 Jan 2018	450	450	-		-	Stock Option (Right to Buy)
Harold E. Selick	None	Sale or transfer of securities back to the company at price $ 0.00 per share.	16 Jan 2018	450	0	-		-	Stock Option (Right to Buy)
Nassim Usman	Director, President and CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	12 Jan 2018	95,000	95,000	-		-	Stock Option(Right to Buy)
Fletcher Payne	Chief Financial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	12 Jan 2018	26,000	26,000	-		-	Stock Option (Right to Buy)
Howard Levy	Chief Medical Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	12 Jan 2018	33,000	33,000	-		-	Stock Option(Right to Buy)
Edward Williams	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	02 Jan 2018	10,000	10,000	-		-	Stock Option (Right to Buy)
Andrea S. Hunt	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	25 Oct 2017	10,000	10,000	-		-	Stock Option (Right to Buy)
Harold E. Selick	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	13 Jul 2017	10,000	10,000	-		-	Stock Option (Right to Buy)
Stephen A. Hill	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	13 Jul 2017	10,000	10,000	-		-	Stock Option (Right to Buy)
Augustine J. Lawlor	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	13 Jul 2017	10,000	10,000	-		-	Stock Option (Right to Buy)
John P Richard	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	13 Jul 2017	10,000	10,000	-		-	Stock Option (Right to Buy)
Desouza B Errol	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	13 Jul 2017	10,000	10,000	-		-	Stock Option (Right to Buy)
Nassim Usman	Director, President & CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	11 Jul 2017	275,000	275,000	-		-	Stock Option (Right to Buy)
Fletcher Payne	Chief Financial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	11 Jul 2017	75,000	75,000	-		-	Stock Option (Right to Buy)
Howard Levy	Chief Medical Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	11 Jul 2017	95,000	95,000	-		-	Stock Option (Right to Buy)
Harold E. Selick	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	09 Jun 2016	7,500	7,500	-		-	Stock Option (Right to Buy)
Stephen A. Hill	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	09 Jun 2016	7,500	7,500	-		-	Stock Option (Right to Buy)
Augustine J. Lawlor	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	09 Jun 2016	7,500	7,500	-		-	Stock Option (Right to Buy)
John P Richard	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	09 Jun 2016	7,500	7,500	-		-	Stock Option (Right to Buy)
Desouza B Errol	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	09 Jun 2016	7,500	7,500	-		-	Stock Option (Right to Buy)
Howard Levy	Chief Medical Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	18 Apr 2016	100,000	100,000	-		-	Stock Option (Right to Buy)
Stephen A. Hill	None	Purchase of securities on an exchange or from another person at price $ 0.00 per share.	17 Dec 2015	5,000	20,711	-		-	Common Stock
Nassim Usman	Director, President & CEO	Purchase of securities on an exchange or from another person at price $ 0.00 per share.	17 Dec 2015	4,000	78,375	-		-	Common Stock
Fletcher Payne	Chief Financial Officer	Purchase of securities on an exchange or from another person at price $ 0.00 per share.	17 Dec 2015	10,000	25,032	-		-	Common Stock
Harold E. Selick	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	22 Oct 2015	6,750	6,750	-		-	Stock Option (Right to Buy)
Stephen A. Hill	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	22 Oct 2015	6,750	6,750	-		-	Stock Option (Right to Buy)
Augustine J. Lawlor	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	22 Oct 2015	6,750	6,750	-		-	Stock Option (Right to Buy)
John P. Richard	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	22 Oct 2015	6,750	6,750	-		-	Stock Option (Right to Buy)
Desouza B Errol	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	22 Oct 2015	6,750	6,750	-		-	Stock Option (Right to Buy)
Nassim Usman	Director, President & CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	22 Oct 2015	153,572	153,572	-		-	Stock Option (Right to Buy)
Edwin L. Madison	Chief Scientific Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	22 Oct 2015	58,572	58,572	-		-	Stock Option (Right to Buy)
Fletcher Payne	Chief Financial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	22 Oct 2015	28,572	28,572	-		-	Stock Option (Right to Buy)
Stephen A. Hill	None	Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share.	28 Aug 2015	12,146	15,711	-		-	Common Stock
Harold E. Selick	None	Other type of transaction at price $ 0.00 per share.	20 Aug 2015	287	287	-		-	Warrant (Right to Buy)
Harold E. Selick	None	Other type of transaction at price $ 0.00 per share.	20 Aug 2015	16,232	16,232	-		-	Common Stock
Harold E. Selick	None	Other type of transaction at price $ 0.00 per share.	20 Aug 2015	2,966	2,966	-		-	Stock Option (Right to Buy)
Harold E. Selick	None	Other type of transaction at price $ 0.00 per share.	20 Aug 2015	382	16,614	-		-	Common Stock
Augustine J. Lawlor	None	Other type of transaction at price $ 0.00 per share.	20 Aug 2015	1,041,024	1,041,024	-		-	Common Stock
Augustine J. Lawlor	None	Other type of transaction at price $ 0.00 per share.	20 Aug 2015	2,254	2,254	-		-	Warrant (Right to Buy)
Augustine J. Lawlor	None	Other type of transaction at price $ 0.00 per share.	20 Aug 2015	14,056	14,056	-		-	Warrant (Right to Buy)
Augustine J. Lawlor	None	Other type of transaction at price $ 0.00 per share.	20 Aug 2015	11,383	11,383	-		-	Warrant (Right to Buy)
Jeff W. Himawan	Director, Ten Percent Owner	Other type of transaction at price $ 0.00 per share.	20 Aug 2015	220	220	-		-	Warrant (Right to Buy)
Jeff W. Himawan	Director, Ten Percent Owner	Other type of transaction at price $ 0.00 per share.	20 Aug 2015	556	556	-		-	Warrant (Right to Buy)
Jeff W. Himawan	Director, Ten Percent Owner	Other type of transaction at price $ 0.00 per share.	20 Aug 2015	1,068,790	1,068,790	-		-	Common Stock
Jeff W. Himawan	Director, Ten Percent Owner	Other type of transaction at price $ 0.00 per share.	20 Aug 2015	96	96	-		-	Warrant (Right to Buy)
Jeff W. Himawan	Director, Ten Percent Owner	Other type of transaction at price $ 0.00 per share.	20 Aug 2015	21,926	21,926	-		-	Warrant (Right to Buy)
Jeff W. Himawan	Director, Ten Percent Owner	Other type of transaction at price $ 0.00 per share.	20 Aug 2015	77,059	1,145,849	-		-	Common Stock
Jeff W. Himawan	Director, Ten Percent Owner	Other type of transaction at price $ 0.00 per share.	20 Aug 2015	3,065	3,065	-		-	Warrant (Right to Buy)
Jeff W. Himawan	Director, Ten Percent Owner	Other type of transaction at price $ 0.00 per share.	20 Aug 2015	1,280	1,280	-		-	Warrant (Right to Buy)
Jeff W. Himawan	Director, Ten Percent Owner	Other type of transaction at price $ 0.00 per share.	20 Aug 2015	687	687	-		-	Warrant (Right to Buy)
Jeff W. Himawan	Director, Ten Percent Owner	Other type of transaction at price $ 0.00 per share.	20 Aug 2015	17,757	17,757	-		-	Warrant (Right to Buy)
Jeff W. Himawan	Director, Ten Percent Owner	Other type of transaction at price $ 0.00 per share.	20 Aug 2015	1,580	1,580	-		-	Warrant (Right to Buy)
Jeff W. Himawan	Director, Ten Percent Owner	Other type of transaction at price $ 0.00 per share.	20 Aug 2015	33,503	1,179,352	-		-	Common Stock
Nassim Usman	Director, President and CEO	Other type of transaction at price $ 0.00 per share.	20 Aug 2015	29	29	-		-	Warrant (Right to Buy)
Nassim Usman	Director, President and CEO	Other type of transaction at price $ 0.00 per share.	20 Aug 2015	8,786	8,786	-		-	Stock Option (Right to Buy)
Nassim Usman	Director, President and CEO	Other type of transaction at price $ 0.00 per share.	20 Aug 2015	60,847	60,847	-		-	Common Stock
Nassim Usman	Director, President and CEO	Other type of transaction at price $ 0.00 per share.	20 Aug 2015	22,508	22,508	-		-	Stock Option (Right to Buy)
Nassim Usman	Director, President and CEO	Other type of transaction at price $ 0.00 per share.	20 Aug 2015	61,118	61,118	-		-	Stock Option (Right to Buy)
Nassim Usman	Director, President and CEO	Other type of transaction at price $ 0.00 per share.	20 Aug 2015	13,528	74,375	-		-	Common Stock
Edwin L. Madison	Chief Scientific Officer	Other type of transaction at price $ 0.00 per share.	20 Aug 2015	11,254	11,254	-		-	Stock Option (Right to Buy)
Edwin L. Madison	Chief Scientific Officer	Other type of transaction at price $ 0.00 per share.	20 Aug 2015	3,820	3,820	-		-	Stock Option (Right to Buy)
Edwin L. Madison	Chief Scientific Officer	Other type of transaction at price $ 0.00 per share.	20 Aug 2015	29	29	-		-	Warrant (Right to Buy)
Edwin L. Madison	Chief Scientific Officer	Other type of transaction at price $ 0.00 per share.	20 Aug 2015	6,501	6,501	-		-	Stock Option (Right to Buy)
Edwin L. Madison	Chief Scientific Officer	Other type of transaction at price $ 0.00 per share.	20 Aug 2015	26,809	26,809	-		-	Stock Option (Right to Buy)
Edwin L. Madison	Chief Scientific Officer	Other type of transaction at price $ 0.00 per share.	20 Aug 2015	31,008	31,008	-		-	Common Stock
Fletcher Payne	Chief Financial Officer	Other type of transaction at price $ 0.00 per share.	20 Aug 2015	15,032	15,032	-		-	Common Stock
Fletcher Payne	Chief Financial Officer	Other type of transaction at price $ 0.00 per share.	20 Aug 2015	7,320	7,320	-		-	Stock Option (Right to Buy)
Fletcher Payne	Chief Financial Officer	Other type of transaction at price $ 0.00 per share.	20 Aug 2015	14,325	14,325	-		-	Stock Option (Right to Buy)
Fletcher Payne	Chief Financial Officer	Other type of transaction at price $ 0.00 per share.	20 Aug 2015	2,440	2,440	-		-	Stock Option (Right to Buy)
Julia R. Brown	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	04 Aug 2015	12,500	12,500	-		-	Stock Option (Right to Buy)
Alan W. Dunton	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	04 Aug 2015	12,500	12,500	-		-	Stock Option (Right to Buy)
Charles A. Blixt	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	04 Aug 2015	12,500	12,500	-		-	Stock Option (Right to Buy)
Julia R. Brown	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	11 Dec 2014	10,000	10,000	-		-	Common Stock
Alan W. Dunton	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	11 Dec 2014	10,000	10,000	-		-	Common Stock
Charles A. Blixt	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	11 Dec 2014	10,000	10,000	-		-	Common Stock
John P. Richard	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	11 Dec 2014	10,000	15,333	-		-	Common Stock
Desouza B Errol	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	11 Dec 2014	10,000	15,333	-		-	Common Stock
Stephen A. Hill	Director, President & CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	17 Oct 2014	175,000	195,000	-		-	Common Stock
Alan A. Musso	SVP, Fin+Admin, CFO & Treas	Grant, award, or other acquisition of securities at price $ 0.00 per share.	17 Oct 2014	55,000	57,799	-		-	Common Stock
Steven M. Toler	VP, Clin Pharm Sciences	Grant, award, or other acquisition of securities at price $ 0.00 per share.	17 Oct 2014	45,000	46,000	-		-	Common Stock
Patrick C. Rock	SVP, GC and Secretary	Grant, award, or other acquisition of securities at price $ 0.00 per share.	17 Oct 2014	45,000	45,000	-		-	Common Stock
Julia R. Brown	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	12 Jun 2014	12,500	12,500	-		-	Stock Option (Right to Buy)
Alan W. Dunton	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	12 Jun 2014	12,500	12,500	-		-	Stock Option (Right to Buy)
Charles A. Blixt	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	12 Jun 2014	12,500	12,500	-		-	Stock Option (Right to Buy)
John P. Richard	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	12 Jun 2014	17,500	17,500	-		-	Stock Option (Right to Buy)
Desouza B Errol	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	12 Jun 2014	12,500	12,500	-		-	Stock Option (Right to Buy)
Stephen A. Hill	Director, President & CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jan 2014	175,000	175,000	-		-	Stock Option (Right to Buy)
Alan A. Musso	SVP, Fin+Admin, CFO & Treas	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jan 2014	55,000	55,000	-		-	Stock Option (Right to Buy)
Steven M. Toler	VP, Clin Pharm Sciences	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jan 2014	45,000	45,000	-		-	Stock Option (Right to Buy)
David A. Hosford	VP, Clin Dev & Reg Affairs	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jan 2014	45,000	45,000	-		-	Stock Option (Right to Buy)
Patrick C. Rock	SVP, GC and Secretary	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jan 2014	45,000	45,000	-		-	Stock Option (Right to Buy)
John P. Richard	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	08 Jan 2014	10,000	10,000	-		-	Common Stock, $0.001 par value per share
Peter J. Barris	Ten Percent Owner	Sale of securities on an exchange or to another person at price $ 0.00 per share.	05 Dec 2013	1,000	0	-		-	Common Stock
Sandell D Scott	Ten Percent Owner	Sale of securities on an exchange or to another person at price $ 0.00 per share.	05 Dec 2013	1,000	0	-		-	Common Stock
M. James Barrett	Ten Percent Owner	Sale of securities on an exchange or to another person at price $ 0.00 per share.	03 Dec 2013	15,000	0	-		-	Common Stock
M. James Barrett	Ten Percent Owner	Sale of securities on an exchange or to another person at price $ 0.00 per share.	03 Dec 2013	1,000	0	-		-	Common Stock
M. James Barrett	Ten Percent Owner	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	03 Dec 2013	7,500	7,500	-		-	Common Stock
M. James Barrett	Ten Percent Owner	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	03 Dec 2013	7,500	15,000	-		-	Common Stock
M. James Barrett	Ten Percent Owner	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	03 Dec 2013	7,500	0	-		-	Director Stock Option (right to buy)
M. James Barrett	Ten Percent Owner	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	03 Dec 2013	7,500	0	-		-	Director Stock Option (right to buy)
M. James Barrett	Ten Percent Owner	Sale of securities on an exchange or to another person at price $ 0.00 per share.	21 Nov 2013	5,333	1,000	-		-	Common Stock
Peter J. Barris	Ten Percent Owner	Sale of securities on an exchange or to another person at price $ 0.00 per share.	21 Nov 2013	5,333	1,000	-		-	Common Stock
Sandell D Scott	Ten Percent Owner	Sale of securities on an exchange or to another person at price $ 0.00 per share.	21 Nov 2013	5,333	1,000	-		-	Common Stock
Patrick C. Rock	SVP, GC and Secretary	Grant, award, or other acquisition of securities at price $ 0.00 per share.	30 Sep 2013	100,000	100,000	-		-	Common Stock, $0.001 par value per share
Julia R. Brown	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	07 Jun 2013	12,500	12,500	-		-	Stock Option (Right to Buy)
Alan W. Dunton	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	07 Jun 2013	12,500	12,500	-		-	Stock Option (Right to Buy)
Mark B. Skaletsky	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	07 Jun 2013	17,500	17,500	-		-	Stock Option (Right to Buy)
Charles A. Blixt	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	07 Jun 2013	12,500	12,500	-		-	Stock Option (Right to Buy)
John P. Richard	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	07 Jun 2013	12,500	12,500	-		-	Stock Option (Right to Buy)
Desouza B Errol	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	07 Jun 2013	12,500	12,500	-		-	Stock Option (Right to Buy)
M. James Barrett	Ten Percent Owner		03 Jun 2013	1,000	6,333	-		-	Common Stock
M. James Barrett	Ten Percent Owner		03 Jun 2013	1,000	0	-		-	Stock Option (Right to Buy)
Peter J. Barris	Ten Percent Owner		03 Jun 2013	1,000	6,333	-		-	Common Stock
Peter J. Barris	Ten Percent Owner		03 Jun 2013	1,000	0	-		-	Stock Option (Right to Buy)
Sandell D Scott	Ten Percent Owner		03 Jun 2013	1,000	6,333	-		-	Common Stock
Sandell D Scott	Ten Percent Owner		03 Jun 2013	1,000	0	-		-	Stock Option (Right to Buy)
Julia R. Brown	None	Purchase of securities on an exchange or from another person at price $ 0.00 per share.	10 May 2013	6,000	6,000	-		-	Common Stock
Stephen A. Hill	Director, President and CEO	Purchase of securities on an exchange or from another person at price $ 0.00 per share.	08 Mar 2013	10,000	20,000	-		-	Common Stock
Stephen A. Hill	Director, President and CEO	Purchase of securities on an exchange or from another person at price $ 0.00 per share.	08 Mar 2013	10,000	10,000	-		-	Common Stock
Merouane Bencherif	SVP and Senior Scien Fellow	Grant, award, or other acquisition of securities at price $ 0.00 per share.	17 Jan 2013	40,000	40,000	-		-	Stock Option (Right to Buy)
Jefferey P. Brennan	SVP, Bus. and Comm. Dev. & CBO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	17 Jan 2013	65,000	65,000	-		-	Stock Option (Right to Buy)
Alan A. Musso	SVP, Fin+Admin, CFO & Treas	Grant, award, or other acquisition of securities at price $ 0.00 per share.	17 Jan 2013	65,000	65,000	-		-	Stock Option (Right to Buy)
Peter A. Zorn	SVP, Lgl Affrs, GC & Secretary	Grant, award, or other acquisition of securities at price $ 0.00 per share.	17 Jan 2013	65,000	65,000	-		-	Stock Option (Right to Buy)
Karen A. Hicks	VP, Human Resources	Grant, award, or other acquisition of securities at price $ 0.00 per share.	17 Jan 2013	40,000	40,000	-		-	Stock Option (Right to Buy)
Mauri K. Hodges	VP, Fin+Corp Sys & Controller	Grant, award, or other acquisition of securities at price $ 0.00 per share.	17 Jan 2013	40,000	40,000	-		-	Stock Option (Right to Buy)
Steven M. Toler	VP, Clin Pharm Sciences	Grant, award, or other acquisition of securities at price $ 0.00 per share.	17 Jan 2013	45,000	45,000	-		-	Stock Option (Right to Buy)
David A. Hosford	VP, Clin Dev & Reg Affairs	Grant, award, or other acquisition of securities at price $ 0.00 per share.	17 Jan 2013	45,000	45,000	-		-	Stock Option (RIght to Buy)
Stephen A. Hill	Director, President and CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	03 Dec 2012	400,000	400,000	-		-	Stock Option (Right to Buy)
C. Richard Kramlich	Ten Percent Owner		19 Nov 2012	3,333	0	-		-	Stock Option (Right to Buy)
C. Richard Kramlich	Ten Percent Owner		19 Nov 2012	3,333	5,333	-		-	Common Stock
Peter J. Barris	Ten Percent Owner		19 Nov 2012	3,333	0	-		-	Stock Option (Right to Buy)
Peter J. Barris	Ten Percent Owner		19 Nov 2012	3,333	5,333	-		-	Common Stock
Sandell D Scott	Ten Percent Owner		19 Nov 2012	3,333	0	-		-	Stock Option (Right to Buy)
Sandell D Scott	Ten Percent Owner		19 Nov 2012	3,333	5,333	-		-	Common Stock
Mark N. Lampert	Ten Percent Owner	Purchase of securities on an exchange or from another person at price $ 0.00 per share.	14 Nov 2012	378,000	2,977,919	-		-	Common Stock
Mark N. Lampert	Ten Percent Owner	Purchase of securities on an exchange or from another person at price $ 0.00 per share.	14 Nov 2012	217,000	1,713,907	-		-	Common Stock
Mark N. Lampert	Ten Percent Owner	Purchase of securities on an exchange or from another person at price $ 0.00 per share.	07 Nov 2012	31,929	1,827,856	-		-	Common Stock
Mark N. Lampert	Ten Percent Owner	Purchase of securities on an exchange or from another person at price $ 0.00 per share.	07 Nov 2012	17,400	1,052,258	-		-	Common Stock
Mark N. Lampert	Ten Percent Owner	Purchase of securities on an exchange or from another person at price $ 0.00 per share.	07 Nov 2012	8,800	1,034,858	-		-	Common Stock
Mark N. Lampert	Ten Percent Owner	Purchase of securities on an exchange or from another person at price $ 0.00 per share.	07 Nov 2012	14,300	1,795,927	-		-	Common Stock
Mark N. Lampert	Ten Percent Owner	Purchase of securities on an exchange or from another person at price $ 0.00 per share.	31 Oct 2012	21,500	1,026,058	-		-	Common Stock
Mark N. Lampert	Ten Percent Owner	Purchase of securities on an exchange or from another person at price $ 0.00 per share.	31 Oct 2012	46,700	1,738,827	-		-	Common Stock
Mark N. Lampert	Ten Percent Owner	Purchase of securities on an exchange or from another person at price $ 0.00 per share.	31 Oct 2012	36,100	1,781,627	-		-	Common Stock
Mark N. Lampert	Ten Percent Owner	Purchase of securities on an exchange or from another person at price $ 0.00 per share.	31 Oct 2012	23,400	1,004,558	-		-	CommonStock
Mark N. Lampert	Ten Percent Owner	Purchase of securities on an exchange or from another person at price $ 0.00 per share.	31 Oct 2012	5,300	981,158	-		-	Common Stock
Mark N. Lampert	Ten Percent Owner	Purchase of securities on an exchange or from another person at price $ 0.00 per share.	31 Oct 2012	6,700	1,745,527	-		-	Common Stock
G. Steven Burrill	None	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	31 Jul 2012	4,333	4,333	-		-	Common Stock
G. Steven Burrill	None	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	31 Jul 2012	4,333	0	-		-	Stock Option (Right to Buy)
Mark B. Skaletsky	Director, Member, Office of the Chairman	Grant, award, or other acquisition of securities at price $ 0.00 per share.	11 Jun 2012	57,500	57,500	-		-	Stock Option (Right to Buy)
John P. Richard	None	Purchase of securities on an exchange or from another person at price $ 0.00 per share.	08 Jun 2012	7,500	7,500	-		-	Common Stock
Julia R. Brown	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	07 Jun 2012	7,500	7,500	-		-	Stock Option (Right to Buy)
G. Steven Burrill	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	07 Jun 2012	7,500	7,500	-		-	Stock Option (Right to Buy)
Alan W. Dunton	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	07 Jun 2012	7,500	7,500	-		-	Stock Option (Right to Buy)
M. James Barrett	Director, Ten Percent Owner	Grant, award, or other acquisition of securities at price $ 0.00 per share.	07 Jun 2012	7,500	7,500	-		-	Director Stock Option (Right to Buy)
Ralph Snyderman	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	07 Jun 2012	7,500	7,500	-		-	Stock Option (Right to Buy)
Charles A. Blixt	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	07 Jun 2012	7,500	7,500	-		-	Stock Option (Right to Buy)
John P. Richard	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	07 Jun 2012	7,500	7,500	-		-	Stock Option (Right to Buy)
Desouza B Errol	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	07 Jun 2012	7,500	7,500	-		-	Stock Option (Right to Buy)
Merouane Bencherif	SVP, Preclinical Research	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	18 May 2012	15,938	15,938	-		-	Common Stock
Merouane Bencherif	SVP, Preclinical Research	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	18 May 2012	15,938	7,970	-		-	Stock Option (Right to Buy)
J. Donald deBethizy	Director, President and CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	04 May 2012	135,000	135,000	-		-	Stock Option (Right to Buy)
Merouane Bencherif	SVP, Preclinical Research	Grant, award, or other acquisition of securities at price $ 0.00 per share.	04 May 2012	90,000	90,000	-		-	Stock Option (Right to Buy)
Jefferey P. Brennan	SVP - Bus. & Commercial Dev.	Grant, award, or other acquisition of securities at price $ 0.00 per share.	04 May 2012	100,000	100,000	-		-	Stock Option (Right to Buy)
Alan A. Musso	SVP, CFO & Treasurer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	04 May 2012	100,000	100,000	-		-	Stock Option (Right to Buy)
Peter A. Zorn	SVP, Lgl Affrs, GC & Secretary	Grant, award, or other acquisition of securities at price $ 0.00 per share.	04 May 2012	100,000	100,000	-		-	Stock Option (Right to Buy)
Karen A. Hicks	VP Human Resources	Grant, award, or other acquisition of securities at price $ 0.00 per share.	04 May 2012	60,000	60,000	-		-	Stock Option (Right to Buy)
Mauri K. Hodges	VP Fin+Corp Sys and Controller	Grant, award, or other acquisition of securities at price $ 0.00 per share.	04 May 2012	60,000	60,000	-		-	Stock Option (Right to Buy)
J. Donald deBethizy	Director, President and CEO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	14 Feb 2012	798	798	-		-	Common Stock
J. Donald deBethizy	Director, President and CEO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	14 Feb 2012	798	0	-		-	Stock Option (Right to Buy)
William S. Caldwell	SVP - Drug Discovery and Dev.	Gift of securities by or to the insider at price $ 0.00 per share.	20 Sep 2011	500	7,235	-		-	Common Stock
William S. Caldwell	SVP - Drug Discovery and Dev.	Gift of securities by or to the insider at price $ 0.00 per share.	20 Sep 2011	500	6,735	-		-	Common Stock
William S. Caldwell	SVP - Drug Discovery and Dev.	Gift of securities by or to the insider at price $ 0.00 per share.	20 Sep 2011	500	500	-		-	Common Stock
John P. Richard	None	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	01 Jul 2011	2,500	2,500	-		-	Stock Option (Right to Buy)
John P. Richard	None	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	01 Jul 2011	2,500	7,833	-		-	Common Stock
John P. Richard	None	Sale of securities on an exchange or to another person at price $ 0.00 per share.	01 Jul 2011	2,500	5,333	-		-	Common Stock
Julia R. Brown	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	15 Jun 2011	7,500	7,500	-		-	Stock Option (Right to Buy)
G. Steven Burrill	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	15 Jun 2011	7,500	7,500	-		-	Stock Option (Right to Buy)
Alan W. Dunton	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	15 Jun 2011	7,500	7,500	-		-	Stock Option (Right to Buy)
Mark B. Skaletsky	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	15 Jun 2011	12,500	12,500	-		-	Stock Option (Right to Buy)
M. James Barrett	Director, Ten Percent Owner	Grant, award, or other acquisition of securities at price $ 0.00 per share.	15 Jun 2011	7,500	7,500	-		-	Director Stock Option (Right to Buy)
Ralph Snyderman	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	15 Jun 2011	7,500	7,500	-		-	Stock Option (Right to Buy)
Charles A. Blixt	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	15 Jun 2011	7,500	7,500	-		-	Stock Option (Right to Buy)
John P. Richard	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	15 Jun 2011	7,500	7,500	-		-	Stock Option (Right to Buy)
Desouza B Errol	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	15 Jun 2011	7,500	7,500	-		-	Stock Option (Right to Buy)
Alan A. Musso	SVP, CFO & Treasurer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	07 Jun 2011	11,627	0	-		-	Stock Option (Right to Buy)
Alan A. Musso	SVP, CFO & Treasurer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	07 Jun 2011	2,880	0	-		-	Stock Option (Right to Buy)
Alan A. Musso	SVP, CFO & Treasurer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	07 Jun 2011	16,368	49,107	-		-	Stock Option (Right to Buy)
Alan A. Musso	SVP, CFO & Treasurer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	07 Jun 2011	11,627	14,426	-		-	Common Stock
Alan A. Musso	SVP, CFO & Treasurer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	07 Jun 2011	2,880	17,306	-		-	Common Stock
Alan A. Musso	SVP, CFO & Treasurer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	07 Jun 2011	16,368	33,674	-		-	Common Stock
Alan A. Musso	SVP, CFO & Treasurer	Sale of securities on an exchange or to another person at price $ 0.00 per share.	07 Jun 2011	30,875	2,799	-		-	Common Stock
Julia R. Brown	None	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	13 May 2011	9,100	9,100	-		-	Common Stock
Julia R. Brown	None	Sale of securities on an exchange or to another person at price $ 0.00 per share.	13 May 2011	9,100	0	-		-	Common Stock
Julia R. Brown	None	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	13 May 2011	9,100	3,400	-		-	Stock Option (Right to Buy)
G. Steven Burrill	None	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	10 May 2011	16,948	16,948	-		-	Common Stock
G. Steven Burrill	None	Sale of securities on an exchange or to another person at price $ 0.00 per share.	10 May 2011	16,948	0	-		-	Common Stock
G. Steven Burrill	None	Sale of securities on an exchange or to another person at price $ 0.00 per share.	10 May 2011	2,000	0	-		-	Common Stock
G. Steven Burrill	None	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	10 May 2011	10,552	10,552	-		-	Common Stock
G. Steven Burrill	None	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	10 May 2011	7,500	18,052	-		-	Common Stock
G. Steven Burrill	None	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	10 May 2011	7,500	25,552	-		-	Common Stock
G. Steven Burrill	None	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	10 May 2011	7,500	33,052	-		-	Common Stock
G. Steven Burrill	None	Sale of securities on an exchange or to another person at price $ 0.00 per share.	10 May 2011	33,052	0	-		-	Common Stock
G. Steven Burrill	None	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	10 May 2011	16,948	3,052	-		-	Stock Option (Right to Buy)
G. Steven Burrill	None	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	10 May 2011	3,052	0	-		-	Stock Option (Right to Buy)
G. Steven Burrill	None	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	10 May 2011	7,500	0	-		-	Stock Option (Right to Buy)
G. Steven Burrill	None	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	10 May 2011	7,500	0	-		-	Stock Option (Right to Buy)
G. Steven Burrill	None	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	10 May 2011	7,500	0	-		-	Stock Option (Right to Buy)
G. Steven Burrill	None	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	10 May 2011	7,500	0	-		-	Stock Option (Right to Buy)
John P. Richard	None	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	01 Apr 2011	2,500	7,833	-		-	Common Stock
John P. Richard	None	Sale of securities on an exchange or to another person at price $ 0.00 per share.	01 Apr 2011	2,500	5,333	-		-	Common Stock
John P. Richard	None	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	01 Apr 2011	2,500	5,000	-		-	Stock Option (Right to Buy)
William S. Caldwell	SVP - Drug Discovery and Dev.	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	31 Mar 2011	2,655	18,595	-		-	Stock Option (Right to Buy)
William S. Caldwell	SVP - Drug Discovery and Dev.	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	31 Mar 2011	2,655	10,390	-		-	Common Stock
William S. Caldwell	SVP - Drug Discovery and Dev.	Sale of securities on an exchange or to another person at price $ 0.00 per share.	31 Mar 2011	2,655	7,735	-		-	Common Stock
J. Donald deBethizy	Director, President and CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	29 Mar 2011	105,000	105,000	-		-	Stock Option (Right to Buy)
Merouane Bencherif	SVP, Preclinical Research	Grant, award, or other acquisition of securities at price $ 0.00 per share.	29 Mar 2011	40,000	40,000	-		-	Stock Option (Right to Buy)
Jefferey P. Brennan	SVP - Bus. & Commercial Dev.	Grant, award, or other acquisition of securities at price $ 0.00 per share.	29 Mar 2011	50,000	50,000	-		-	Stock Option (Right to Buy)
William S. Caldwell	SVP - Drug Discovery and Dev.	Grant, award, or other acquisition of securities at price $ 0.00 per share.	29 Mar 2011	40,000	40,000	-		-	Stock Option (Right to Buy)
Geoffrey C. Dunbar	SVP, Clin. Dev. & Reg. Affairs	Grant, award, or other acquisition of securities at price $ 0.00 per share.	29 Mar 2011	55,500	55,500	-		-	Stock Option (Right to Buy)
Alan A. Musso	SVP, CFO & Treasurer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	29 Mar 2011	50,000	50,000	-		-	Stock Option (Right to Buy)
Peter A. Zorn	SVP, Lgl Affrs, GC & Secretary	Grant, award, or other acquisition of securities at price $ 0.00 per share.	29 Mar 2011	50,000	50,000	-		-	Stock Option (Right to Buy)
Karen A. Hicks	VP Human Resources	Grant, award, or other acquisition of securities at price $ 0.00 per share.	29 Mar 2011	30,500	30,500	-		-	Stock Option (Right to Buy)
Mauri K. Hodges	VP Fin+Corp Sys and Controller	Grant, award, or other acquisition of securities at price $ 0.00 per share.	29 Mar 2011	30,500	30,500	-		-	Stock Option (Right to Buy)
Mauri K. Hodges	VP Fin + Corp Sys & Controller	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	09 Mar 2011	1,500	2,659	-		-	Common Stock
Mauri K. Hodges	VP Fin + Corp Sys & Controller	Sale of securities on an exchange or to another person at price $ 0.00 per share.	09 Mar 2011	1,500	1,159	-		-	Common Stock
Mauri K. Hodges	VP Fin + Corp Sys & Controller	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	09 Mar 2011	1,500	6,198	-		-	Stock Option (Right to Buy)
Mauri K. Hodges	VP Fin + Corp Sys & Controller	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	03 Mar 2011	5,030	8,198	-		-	Stock Option (Right to Buy)
Mauri K. Hodges	VP Fin + Corp Sys & Controller	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	03 Mar 2011	500	7,698	-		-	Stock Option (Right to Buy)
Mauri K. Hodges	VP Fin + Corp Sys & Controller	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	03 Mar 2011	5,030	6,189	-		-	Common Stock
Mauri K. Hodges	VP Fin + Corp Sys & Controller	Sale of securities on an exchange or to another person at price $ 0.00 per share.	03 Mar 2011	5,030	1,159	-		-	Common Stock
Mauri K. Hodges	VP Fin + Corp Sys & Controller	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	03 Mar 2011	500	1,659	-		-	Common Stock
Mauri K. Hodges	VP Fin + Corp Sys & Controller	Sale of securities on an exchange or to another person at price $ 0.00 per share.	03 Mar 2011	500	1,159	-		-	Common Stock
Jefferey P. Brennan	SVP - Bus. & Commercial Dev.	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	01 Mar 2011	1,264	1,264	-		-	Common Stock
Jefferey P. Brennan	SVP - Bus. & Commercial Dev.	Sale of securities on an exchange or to another person at price $ 0.00 per share.	01 Mar 2011	1,264	0	-		-	Common Stock
Jefferey P. Brennan	SVP - Bus. & Commercial Dev.	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	01 Mar 2011	1,264	31,394	-		-	Stock Option (Right to Buy)
Karen A. Hicks	VP Human Resources	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	01 Mar 2011	468	468	-		-	Common Stock
Karen A. Hicks	VP Human Resources	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	01 Mar 2011	775	1,243	-		-	Common Stock
Karen A. Hicks	VP Human Resources	Sale of securities on an exchange or to another person at price $ 0.00 per share.	01 Mar 2011	1,243	0	-		-	Common Stock
Karen A. Hicks	VP Human Resources	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	01 Mar 2011	468	32	-		-	Stock Option (Right to Buy)
Karen A. Hicks	VP Human Resources	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	01 Mar 2011	775	2,325	-		-	Stock Option (Right to Buy)
Mauri K. Hodges	VP Fin + Corp Sys & Controller	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	01 Mar 2011	200	1,359	-		-	Common Stock
Mauri K. Hodges	VP Fin + Corp Sys & Controller	Sale of securities on an exchange or to another person at price $ 0.00 per share.	01 Mar 2011	200	1,159	-		-	Common Stock
Mauri K. Hodges	VP Fin + Corp Sys & Controller	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	01 Mar 2011	12,703	13,428	-		-	Stock Option (Right to Buy)
Mauri K. Hodges	VP Fin + Corp Sys & Controller	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	01 Mar 2011	200	13,228	-		-	Stock Option (Right to Buy)
Mauri K. Hodges	VP Fin + Corp Sys & Controller	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	01 Mar 2011	12,703	13,862	-		-	Common Stock
Mauri K. Hodges	VP Fin + Corp Sys & Controller	Sale of securities on an exchange or to another person at price $ 0.00 per share.	01 Mar 2011	12,703	1,159	-		-	Common Stock
William S. Caldwell	SVP - Drug Discovery and Dev.	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	28 Feb 2011	15,481	0	-		-	Stock Option (Right to Buy)
William S. Caldwell	SVP - Drug Discovery and Dev.	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	28 Feb 2011	11,360	31,472	-		-	Stock Option (Right to Buy)
William S. Caldwell	SVP - Drug Discovery and Dev.	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	28 Feb 2011	15,481	23,216	-		-	Common Stock
William S. Caldwell	SVP - Drug Discovery and Dev.	Sale of securities on an exchange or to another person at price $ 0.00 per share.	28 Feb 2011	15,481	7,735	-		-	Common Stock
William S. Caldwell	SVP - Drug Discovery and Dev.	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	28 Feb 2011	11,360	19,095	-		-	Common Stock
William S. Caldwell	SVP - Drug Discovery and Dev.	Sale of securities on an exchange or to another person at price $ 0.00 per share.	28 Feb 2011	11,360	7,735	-		-	Common Stock
William S. Caldwell	SVP - Drug Discovery and Dev.	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	16 Feb 2011	16,655	21,250	-		-	Stock Option (Right to Buy)
William S. Caldwell	SVP - Drug Discovery and Dev.	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	16 Feb 2011	16,655	24,390	-		-	Common Stock
William S. Caldwell	SVP - Drug Discovery and Dev.	Sale of securities on an exchange or to another person at price $ 0.00 per share.	16 Feb 2011	16,655	7,735	-		-	Common Stock
John P. Richard	None	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	18 Jan 2011	2,500	7,833	-		-	Common Stock
John P. Richard	None	Sale of securities on an exchange or to another person at price $ 0.00 per share.	18 Jan 2011	2,500	5,333	-		-	Common Stock
John P. Richard	None	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	18 Jan 2011	5,000	10,333	-		-	Common Stock
John P. Richard	None	Sale of securities on an exchange or to another person at price $ 0.00 per share.	18 Jan 2011	5,000	5,333	-		-	Common Stock
John P. Richard	None	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	18 Jan 2011	2,500	5,000	-		-	Stock Option (Right to Buy)
John P. Richard	None	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	18 Jan 2011	5,000	0	-		-	Stock Option (Right to Buy)
Merouane Bencherif	SVP, Preclinical Research	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	18 Jan 2011	22,800	7,951	-		-	Stock Option (Right to Buy)
Merouane Bencherif	SVP, Preclinical Research	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	18 Jan 2011	7,951	0	-		-	Stock Option (Right to Buy)
Merouane Bencherif	SVP, Preclinical Research	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	18 Jan 2011	22,252	0	-		-	Stock Option (Right to Buy)
Merouane Bencherif	SVP, Preclinical Research	Sale of securities on an exchange or to another person at price $ 0.00 per share.	18 Jan 2011	30,203	0	-		-	Common Stock
Merouane Bencherif	SVP, Preclinical Research	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	18 Jan 2011	22,800	22,800	-		-	Common Stock
Merouane Bencherif	SVP, Preclinical Research	Sale of securities on an exchange or to another person at price $ 0.00 per share.	18 Jan 2011	22,800	0	-		-	Common Stock
Merouane Bencherif	SVP, Preclinical Research	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	18 Jan 2011	7,951	7,951	-		-	Common Stock
Merouane Bencherif	SVP, Preclinical Research	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	18 Jan 2011	22,252	30,203	-		-	Common Stock
Karen A. Hicks	VP Human Resources	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	13 Jan 2011	3,369	3,369	-		-	Common Stock
Karen A. Hicks	VP Human Resources	Sale of securities on an exchange or to another person at price $ 0.00 per share.	13 Jan 2011	3,369	0	-		-	Common Stock
Karen A. Hicks	VP Human Resources	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	13 Jan 2011	1,719	1,719	-		-	Common Stock
Karen A. Hicks	VP Human Resources	Sale of securities on an exchange or to another person at price $ 0.00 per share.	13 Jan 2011	1,719	0	-		-	Common Stock
Karen A. Hicks	VP Human Resources	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	13 Jan 2011	3,369	15,469	-		-	Stock Option (Right to Buy)
Karen A. Hicks	VP Human Resources	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	13 Jan 2011	1,719	13,750	-		-	Stock Option (Right to Buy)
Karen A. Hicks	VP Human Resources	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	11 Jan 2011	6,006	6,006	-		-	Common Stock
Karen A. Hicks	VP Human Resources	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	11 Jan 2011	10,531	0	-		-	Stock Option (Right to Buy)
Karen A. Hicks	VP Human Resources	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	11 Jan 2011	3,294	9,106	-		-	Stock Option (Right to Buy)
Karen A. Hicks	VP Human Resources	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	11 Jan 2011	6,006	3,100	-		-	Stock Option (Right to Buy)
Karen A. Hicks	VP Human Resources	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	11 Jan 2011	5,225	18,838	-		-	Stock Option (Right to Buy)
Karen A. Hicks	VP Human Resources	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	11 Jan 2011	5,225	11,231	-		-	Common Stock
Karen A. Hicks	VP Human Resources	Sale of securities on an exchange or to another person at price $ 0.00 per share.	11 Jan 2011	11,231	0	-		-	Common Stock
Karen A. Hicks	VP Human Resources	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	11 Jan 2011	10,531	10,531	-		-	Common Stock
Karen A. Hicks	VP Human Resources	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	11 Jan 2011	3,294	13,825	-		-	Common Stock
Karen A. Hicks	VP Human Resources	Sale of securities on an exchange or to another person at price $ 0.00 per share.	11 Jan 2011	13,825	0	-		-	Common Stock
Alan A. Musso	SVP, CFO & Treasurer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	21 Dec 2010	15,535	18,334	-		-	Common Stock
Alan A. Musso	SVP, CFO & Treasurer	Sale of securities on an exchange or to another person at price $ 0.00 per share.	21 Dec 2010	15,535	2,799	-		-	Common Stock
Alan A. Musso	SVP, CFO & Treasurer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	21 Dec 2010	4,881	7,680	-		-	Common Stock
Alan A. Musso	SVP, CFO & Treasurer	Sale of securities on an exchange or to another person at price $ 0.00 per share.	21 Dec 2010	4,881	2,799	-		-	Common Stock
Alan A. Musso	SVP, CFO & Treasurer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	21 Dec 2010	8,789	0	-		-	Stock Option (Right to Buy)
Alan A. Musso	SVP, CFO & Treasurer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	21 Dec 2010	6,746	16,508	-		-	Stock Option (Right to Buy)
Alan A. Musso	SVP, CFO & Treasurer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	21 Dec 2010	4,881	11,627	-		-	Stock Option (Right to Buy)
Geoffrey C. Dunbar	SVP, Clin. Dev. & Reg. Affairs	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	17 Dec 2010	2,100	0	-		-	Stock Option (Right to Buy)
Geoffrey C. Dunbar	SVP, Clin. Dev. & Reg. Affairs	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	17 Dec 2010	6,782	0	-		-	Stock Option (Right to Buy)
Geoffrey C. Dunbar	SVP, Clin. Dev. & Reg. Affairs	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	17 Dec 2010	2,100	2,100	-		-	Stock Option (Right to Buy)
Geoffrey C. Dunbar	SVP, Clin. Dev. & Reg. Affairs	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	17 Dec 2010	2,100	3,253	-		-	Common Stock
Geoffrey C. Dunbar	SVP, Clin. Dev. & Reg. Affairs	Sale of securities on an exchange or to another person at price $ 0.00 per share.	17 Dec 2010	2,100	1,153	-		-	Common Stock
Geoffrey C. Dunbar	SVP, Clin. Dev. & Reg. Affairs	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	17 Dec 2010	8,882	10,035	-		-	Common Stock
Geoffrey C. Dunbar	SVP, Clin. Dev. & Reg. Affairs	Sale of securities on an exchange or to another person at price $ 0.00 per share.	17 Dec 2010	8,882	1,153	-		-	Common Stock
Geoffrey C. Dunbar	SVP, Clin. Dev. & Reg. Affairs	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	16 Dec 2010	200	4,200	-		-	Stock Option (Right to Buy)
Geoffrey C. Dunbar	SVP, Clin. Dev. & Reg. Affairs	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	16 Dec 2010	200	1,353	-		-	Common Stock
Geoffrey C. Dunbar	SVP, Clin. Dev. & Reg. Affairs	Sale of securities on an exchange or to another person at price $ 0.00 per share.	16 Dec 2010	200	1,153	-		-	Common Stock
Mauri K. Hodges	VP Fin + Corp Sys & Controller	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	16 Dec 2010	2,700	3,859	-		-	Common Stock
Mauri K. Hodges	VP Fin + Corp Sys & Controller	Sale of securities on an exchange or to another person at price $ 0.00 per share.	16 Dec 2010	2,700	1,159	-		-	Common Stock
Mauri K. Hodges	VP Fin + Corp Sys & Controller	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	16 Dec 2010	2,700	18,390	-		-	Stock Option (Right to Buy)
Jefferey P. Brennan	SVP - Bus. & Commercial Dev.	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	13 Dec 2010	10,000	10,000	-		-	Common Stock
Jefferey P. Brennan	SVP - Bus. & Commercial Dev.	Sale of securities on an exchange or to another person at price $ 0.00 per share.	13 Dec 2010	10,000	0	-		-	Common Stock
Jefferey P. Brennan	SVP - Bus. & Commercial Dev.	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	13 Dec 2010	10,000	32,658	-		-	Stock Option (Right to Buy)
William S. Caldwell	SVP - Drug Discovery and Dev.	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	13 Dec 2010	12,000	0	-		-	Stock Option (Right to Buy)
William S. Caldwell	SVP - Drug Discovery and Dev.	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	13 Dec 2010	12,000	19,735	-		-	Common Stock
William S. Caldwell	SVP - Drug Discovery and Dev.	Sale of securities on an exchange or to another person at price $ 0.00 per share.	13 Dec 2010	12,000	7,735	-		-	Common Stock
Merouane Bencherif	SVP, Preclinical Research	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	10 Dec 2010	7,194	30,751	-		-	Stock Option (Right to Buy)
Merouane Bencherif	SVP, Preclinical Research	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	10 Dec 2010	14,275	14,280	-		-	Stock Option (Right to Buy)
Merouane Bencherif	SVP, Preclinical Research	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	10 Dec 2010	10,624	23,908	-		-	Stock Option (Right to Buy)
Merouane Bencherif	SVP, Preclinical Research	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	10 Dec 2010	7,194	7,194	-		-	Common Stock
Merouane Bencherif	SVP, Preclinical Research	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	10 Dec 2010	14,275	21,469	-		-	Common Stock
Merouane Bencherif	SVP, Preclinical Research	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	10 Dec 2010	10,624	32,093	-		-	Common Stock
Merouane Bencherif	SVP, Preclinical Research	Sale of securities on an exchange or to another person at price $ 0.00 per share.	10 Dec 2010	32,093	0	-		-	Common Stock
Geoffrey C. Dunbar	SVP, Clin. Dev. & Reg. Affairs	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	08 Dec 2010	6,354	0	-		-	Stock Option (Right to Buy)
Geoffrey C. Dunbar	SVP, Clin. Dev. & Reg. Affairs	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	08 Dec 2010	4,896	0	-		-	Stock Option (Right to Buy)
Geoffrey C. Dunbar	SVP, Clin. Dev. & Reg. Affairs	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	08 Dec 2010	11,250	12,403	-		-	Common Stock

*All Values are in $ Million

Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures

Data as reported to USA Exchanges

View All The Insider Trades disclosures

New 52W High today

Insider Trading disclosures for Catalyst Biosciences Inc

The latest disclosure was made by Nassim Usman in Catalyst Biosciences Inc where a trade of 3,250 Common Stock done at an average price of $0.5 was reported to US exchanges on Aug. 9, 2022.

Screeners based on Insider Trading and SAST parameters